In the present study, we found that DNMT3A contributed significantly to the hypermethylation of SLERCC, leading to the downregulation of SLERCC expression in RCC, which in turn could accelerate the progression and metastasis in RCC by activating the Wnt/β-catenin signaling pathway. The gene discussed is DNMT3A; the disease is renal cell carcinoma.